OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The drug development landscape in Parkinson's
This event will be held in person. Please note slightly the later start time of 12:15pm
Originally a biochemist, Dr Kevin McFarthing’s career included R&D leadership positions in life sciences research products with Amersham, diagnostics with Serono and consumer healthcare with Reckitt Benckiser. He curates the Parkinson’s Hope List (bit.ly/ParkinsonsHopeList), a database of potential therapies in research and clinical stages. Kevin was diagnosed with Parkinson’s in 2012 at the age of 55.
Date:
24 May 2022, 12:15
Venue:
Dorothy Crowfoot Hodgkin Building, off South Parks Road OX1 3QU
Venue Details:
This seminar will be held in the Dorothy Crowfoot Hodgkin Building (Phase II Biochemistry), Ground Floor Seminar Room (20-140). Email: opdc.administrator@dpag.ox.ac.uk for more details.
Speaker:
Dr Kevin McFarthing (Research Advisor, Parkinson’s UK Oxford Branch)
Organising department:
Department of Physiology, Anatomy and Genetics (DPAG)
Organiser:
Lorraine Dyson (University of Oxford)
Organiser contact email address:
opdc.administrator@dpag.ox.ac.uk
Host:
Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of:
OPDC Seminar Series (DPAG)
Booking required?:
Not required
Audience:
Members of the University only
Editors:
Samuel Press,
Lorraine Dyson
